Tender notice
NHS National Pharmaceuticals Transition 2022_1
Notice details
- Published
- Category
- goods
- Buyer region
- North West
- Source
- View official notice
Public buyer
Public buyer
NHS England and NHS ImprovementTender value£1
- Planned startAs published in the notice
- Planned endAs published in the notice
Work description
Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement:
Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)
Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months)
Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)